Literature DB >> 18588766

Effect of patient-related delay in diagnosis on the extent of disease and prognosis in nasopharyngeal carcinoma.

Liming Sheng1, Yongjie Shui, Li Shen, Qichun Wei.   

Abstract

BACKGROUND: The reasons causing the patient-related delay in diagnosis (PRDD) and the effects of PRDD on the extent of disease and prognosis in the nasopharyngeal carcinoma (NPC) remain uncertain. The aim of this study was to investigate the status of PRDD and evaluate the relationship between PRDD and prognostic factors of NPC.
METHODS: The data of 216 patients with NPC, from 2002 to 2006, were analyzed retrospectively with respect to patient age, gender, smoking status, education experience, living area, and symptoms. PRDD was recorded as the time from initial symptoms to the first visit to a medical doctor. The extent of disease was determined by TNM staging according to the International Union Against Cancer classification in 1997.
RESULTS: PRDD of the analyzed cases ranged from half a month to 24 months, with a mean delay in diagnosis of 5.6 months. Senior residents and low education population tended to have longer PRDD (p < 0.05). There was a significant correlation between PRDD and the degree of invasion, clinical stage of NPC (p < 0.05).
CONCLUSION: Senior residents and low education population tend to have longer PRDD. Delay in diagnosis correlates with the degree of invasion and stage of NPC.

Entities:  

Mesh:

Year:  2008        PMID: 18588766     DOI: 10.2500/ajr.2008.22.3174

Source DB:  PubMed          Journal:  Am J Rhinol        ISSN: 1050-6586


  6 in total

1.  Cancer diagnostic tools to aid decision-making in primary care: mixed-methods systematic reviews and cost-effectiveness analysis.

Authors:  Antonieta Medina-Lara; Bogdan Grigore; Ruth Lewis; Jaime Peters; Sarah Price; Paolo Landa; Sophie Robinson; Richard Neal; William Hamilton; Anne E Spencer
Journal:  Health Technol Assess       Date:  2020-11       Impact factor: 4.014

Review 2.  Is increased time to diagnosis and treatment in symptomatic cancer associated with poorer outcomes? Systematic review.

Authors:  R D Neal; P Tharmanathan; B France; N U Din; S Cotton; J Fallon-Ferguson; W Hamilton; A Hendry; M Hendry; R Lewis; U Macleod; E D Mitchell; M Pickett; T Rai; K Shaw; N Stuart; M L Tørring; C Wilkinson; B Williams; N Williams; J Emery
Journal:  Br J Cancer       Date:  2015-03-31       Impact factor: 7.640

3.  Potential factors associated with clinical stage of nasopharyngeal carcinoma at diagnosis: a case-control study.

Authors:  Jun-Ting Ren; Meng-Yu Li; Xiao-Wen Wang; Wen-Qiong Xue; Ze-Fang Ren; Wei-Hua Jia
Journal:  Chin J Cancer       Date:  2017-09-04

Review 4.  Methodological Approaches to Study Extracellular Vesicle miRNAs in Epstein⁻Barr Virus-Associated Cancers.

Authors:  Li Sun; David G Meckes
Journal:  Int J Mol Sci       Date:  2018-09-18       Impact factor: 5.923

5.  Mitochondrial DNA haplogroup confers genetic susceptibility to nasopharyngeal carcinoma in Chaoshanese from Guangdong, China.

Authors:  Sheng-Ping Hu; Ju-Ping Du; De-Rui Li; Yong-Gang Yao
Journal:  PLoS One       Date:  2014-01-31       Impact factor: 3.240

6.  Effect of COVID-19 Epidemic on Delay of Diagnosis and Treatment Path for Patients with Nasopharyngeal Carcinoma.

Authors:  Youqi Yang; Chunying Shen; Chaosu Hu
Journal:  Cancer Manag Res       Date:  2020-05-25       Impact factor: 3.989

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.